GCL
VINC

Glazer Capital LLC’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Glazer Capital LLC’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,463
Closed -$859K – 403
2020
Q3 		$859K Buy
3,463
+3,013
+670% +$613K 0.04% 185
2020
Q2 		$89K Buy
+450
New +$89.1K 0.01% 163

Other funds holding VINC

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Glazer Capital LLC's VINC Position: Q4 2020 in Review

Glazer Capital LLC sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q4 2020, closing a stake of 3,463 shares — an estimated $859K sold.

Glazer Capital LLC first reported a position in VINC in Q2 2020 and held it in 2 quarters. The position peaked at $859K in Q3 2020. 18 funds tracked by Wall St. Rank hold VINC as of Q4 2020.

  • Glazer Capital LLC reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Glazer Capital LLC sold 3,463 Vincerx Pharma, Inc. Common Stock shares in Q4 2020, an estimated $859K.
  • Glazer Capital LLC first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Glazer Capital LLC's Vincerx Pharma, Inc. Common Stock position peaked at $859K in Q3 2020.
  • 18 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q4 2020.

Based on Glazer Capital LLC's 13F filing for Q4 2020, filed 16 Feb 2021.